COMPANY PROFILE

Meritage Pharma

Explore full profile

Develops prescription products for the treatment of gastrointestinal and atopic diseases

San Diego, United StatesFounded 2008Biotech & Life Sciences

Valuation $100–250M Last recorded · 2015

Headcount <100 Current team size

Total funding $50–100M Disclosed equity funding

Unlock exact values

About Meritage Pharma

Meritage Pharma is a biopharmaceutical company focused on developing and commercializing innovative therapies for the treatment of allergic and inflammatory diseases. The company primarily serves patients suffering from conditions such as eosinophilic esophagitis (EoE), a chronic allergic inflammatory disease of the esophagus. Operating within the healthcare and pharmaceutical market, Meritage Pharma employs a research-driven business model, investing heavily in clinical trials and regulatory approvals to bring its products to market. Revenue is generated through the sale of its proprietary medications and potential partnerships or licensing agreements with larger pharmaceutical companies. The company's strategic focus on niche allergic and inflammatory conditions allows it to address unmet medical needs and improve patient outcomes.

MoreLess Source: Dealroom company data

At a glance

Status: Acquired
Founded: 2008
Headquarters: San Diego, United States
Employees: 1
Open positions: None listed
Dealroom signal: 61.1/100
Industry: Health
Sub-industry: Pharmaceutical
Sector: Biotech & Life Sciences, Biotechnology, Gastroenterology, Healthcare Technologies, Digestion, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model: Manufacturing
Client focus: b2c
Links: Website LinkedIn X

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

4 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
ACQUISITIONOther financing	Feb 2015	$245M	$245M	Shire	—
EARLY VCOther financing	Nov 2011	$6.5M	$26M	MPM BioImpact	—

Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

Meritage Pharma website traffic

Latest recorded traffic for Meritage Pharma is 200 monthly website visits. Meritage Pharma's team grew 0% over the past year.

Latest monthly visits200 1-year team growth0%

Monthly website visitsApr 2016–Aug 2023

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
SPSynergy PharmaceuticalsWe’re igniting change in gastrointestinal (GI) medicine to develop new treatments with the potential to improve the lives of patients	New York City, United States	Operational	39	$18M	—
RBRedHill BiopharmaRedHill (NASDAQ: RDHL) is a specialty biopharmaceutical company focused on proprietary drugs for gastrointestinal diseases	Raleigh, United States	Operational
DNDNALiteAn early-stage preclinical biotechnology company that is making DNA based gene-therapy drugs for the gastrointestinal (GI) tract by leveraging new drug delivery technologies	San Francisco, United States	Operational
NUNutriniaDeveloping pharmaceuticals to treat rare conditions of the gastrointestinal tract	Ramat Gan, Israel	Operational
GPGastrotech PharmaGastrotech Pharma A/S is a newly founded company focusing on medical application of gastrointestinal hormones	Copenhagen, Denmark	Closed
ALAlbireoA biotechnology company, develops therapeutic drugs for gastrointestinal diseases	Boston, United States	Acquired
ENEndoChoiceA platform-technology firm, provides devices, diagnostics and infection control for treating gastrointestinal diseases	Alpharetta, United States	Acquired
BTBiora TherapeuticsClinical laboratory services to provide physicians and patients with accurate, timely and state-of-the-art test results	San Diego, United States	Operational